CUSIP 81750R201COM NEWMCRBQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
36 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Flagship Pioneering, LLC | 1.16M | $17.24M | 0 | Held |
| 2 | Vanguard Group Inc | 324.2K | $4.82M | +12.3K | Added |
| 3 | Susquehanna International Group, LLP | 179.9K | $2.68M | +179.9K | New |
| 4 | Marshall Wace, LLP | 120.2K | $1.79M |
| −5.4K |
| Reduced |
| 5 | Blackrock, Inc. | 103.6K | $1.54M | +1.6K | Added |
| 6 | Vontobel Holding Ltd. | 103.2K | $1.54M | +4.7K | Added |
| 7 | Geode Capital Management, LLC | 86.1K | $1.28M | +1.2K | Added |
| 8 | 683 Capital Management, LLC | 52.3K | $778.4K | +52.3K | New |
| 9 | State Street Corp | 33.9K | $504.4K | +4.2K | Added |
| 10 | Lion Point Capital, LP | 31.6K | $469.8K | +4.4K | Added |
See every fund holding Seres Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders